Only Regulatory Products (API/FDF), Drugs in Developments and News are Updated on this Virtual Booth
Update your Virtual Booth on PharmaCompass, ask us
About
CPhI Worldwide, MilanCPhI Worldwide, Milan
Not Confirmed
Not Confirmed
08-10 October, 2024
Not Confirmed
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Not Confirmed
Not Confirmed
30 September-03 October, 2024
List your booth number for exhibitions, ask us
CONTACT DETAILS
Upload your Marketing & Sales content on your company Virtual Booth, click HERE.
Events
Webinars & Exhibitions
CPhI Worldwide, MilanCPhI Worldwide, Milan
Industry Trade Show
Not Confirmed
08-10 October, 2024
Industry Trade Show
Not Confirmed
28-30 September, 2024
Discovery on TargetDiscovery on Target
Industry Trade Show
Not Confirmed
30 September-03 October, 2024
Digital content
INTERVIEW #SpeakPharma
[Sponsored by another company]https://www.pharmacompass.com/speak-pharma/ice-is-pioneering-sustainability-innovation-in-bile-acid-research-for-neurodegenerative-diseases
VLOG #PharmaReel
[Sponsored by another company]DATA COMPILATION #PharmaFlow
[Sponsored by another company]https://www.pharmacompass.com/radio-compass-blog/2024-us-elections-harris-trump-differ-on-abortion-rights-aca-public-health-spends-agree-on-need-to-cut-drug-prices
09 Sep 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/09/09/2942525/0/en/TILT-Biotherapeutics-Presents-Clinical-Data-on-TILT-123-After-Fully-Intravenous-Delivery-Regimen-at-ESMO-2024.html
28 May 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/05/28/2888715/0/en/TILT-Biotherapeutics-Presents-Clinical-Data-on-TILT-123-in-Ovarian-Cancer-at-ASCO-2024.html
10 Apr 2024
// GLOBENEWSWIRE
https://www.globenewswire.com/news-release/2024/04/10/2860497/0/en/TILT-Biotherapeutics-Presents-Clinical-Data-on-TILT-123-in-Combination-with-KEYTRUDA-pembrolizumab-for-Ovarian-Cancer-at-AACR-2024.html
14 Feb 2024
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2024/02/14/2828826/0/en/TILT-Biotherapeutics-Awarded-USD-2M-Grant-from-US-Department-of-Defense-for-Ovarian-Cancer-Immunotherapy-Research.html
08 Dec 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/12/08/2793021/0/en/TILT-Biotherapeutics-Announces-Positive-Clinical-Data-in-Checkpoint-Resistant-Metastatic-Melanoma-Phase-I-Trial-at-ESMO-Immuno-Oncology-2023.html
06 Nov 2023
// GLOBENEWSWIRE
https://www.globenewswire.com//news-release/2023/11/06/2773739/0/en/TILT-Biotherapeutics-Announces-Positive-Clinical-Data-on-Lead-Asset-TILT-123-at-Society-for-Immunotherapy-of-Cancer-2023.html
ABOUT THIS PAGE
LOOKING FOR A SUPPLIER?